Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Puma Biotechnology (PBYI)

Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Puma Biotech: Q2 Earnings Snapshot

Puma Biotech: Q2 Earnings Snapshot

PBYI : 2.60 (+1.96%)
Puma Biotech: Q1 Earnings Snapshot

Puma Biotech: Q1 Earnings Snapshot

PBYI : 2.60 (+1.96%)
Puma Biotech: Q4 Earnings Snapshot

Puma Biotech: Q4 Earnings Snapshot

PBYI : 2.60 (+1.96%)
Puma Biotech: Q3 Earnings Snapshot

Puma Biotech: Q3 Earnings Snapshot

PBYI : 2.60 (+1.96%)
Puma Biotech: Q2 Earnings Snapshot

Puma Biotech: Q2 Earnings Snapshot

PBYI : 2.60 (+1.96%)
Five Top Companies Fighting for the Treatment of Metastatic Breast Cancer

A significant medical breakthrough is needed in the fight against metastatic breast cancer. According to the American Cancer Society, more than 3.1 million women in the United States have a history of...

LLY : 884.48 (-0.16%)
PBYI : 2.60 (+1.96%)
GILD : 83.94 (+0.12%)
IMGN : 31.23 (unch)
BCTX : 0.8100 (-34.68%)
BCT.TO : 1.07 (-34.36%)
There are Positive Developments in the Treatment of Metastatic Breast Cancer

A significant medical breakthrough is desperately needed in the fight against metastatic breast cancer. As it stands right now, metastatic breast cancer has no cure and has proven resistant to many cancer...

LLY : 884.48 (-0.16%)
PBYI : 2.60 (+1.96%)
GILD : 83.94 (+0.12%)
IMGN : 31.23 (unch)
BCTX : 0.8100 (-34.68%)
BCT.TO : 1.07 (-34.36%)
Five Impressive Metastatic Cancer Treatment Stocks to Own Today

A significant medical breakthrough is desperately needed in the fight against breast cancer. At the moment, according to the American Cancer Society, more than 3.1 million women in the United States alone...

LLY : 884.48 (-0.16%)
PBYI : 2.60 (+1.96%)
GILD : 83.94 (+0.12%)
IMGN : 31.23 (unch)
BCTX : 0.8100 (-34.68%)
BCT.TO : 1.07 (-34.36%)
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on May 1, 2023, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted...

PBYI : 2.60 (+1.96%)
Puma Biotech: Q1 Earnings Snapshot

Puma Biotech: Q1 Earnings Snapshot

PBYI : 2.60 (+1.96%)

Barchart Exclusives

2 High-Yielding Dividend Stocks Set to Benefit from China's Stimulus
While China's stimulus is expected to spur its economic growth, metal and mining companies will also benefit from the recovery in China. BHP and RIO look like 2 high-yielding dividend stocks to buy for investors looking to play China's stimulus. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar